FORM 13F
Page of Name of Reporting Manager: HAMBRECHT & QUIST CAPITAL MANAGEMENT
<TABLE>
<CAPTION>
--------------
(SEC USE ONLY)
- -----------------------------------------------------------------------------------------------------------------------------------
Item 6:
Investment Discretion Item 8:
---------------------- Voting Authority
Item 4: Item 5: (b) (Shares)
Item 2: Item 3: Fair Shares of Shared- (c) Item 7: ------------------
Item 1: Title CUSIP Market Principal (a) As Defined Shared- Managers (a) (b) (c)
Name of Issuer of Class Number Value Amount Sole in Instr. V Other See Instr. V Sole Shared None
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Affymetrix Common 00826T108 7,421,875 50,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Amgen Common 031162100 9,206,250 150,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Aradigm Common 038505103 7,306,250 350,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Biofield Common 090591207 878,766 878,769 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Biomatrix Common 09060P102 7,110,420 278,840 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Biopure Common 09065H915 5,654,664 169,746 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
BioTransplant Common 09066Y107 7,615,036 712,519 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Biovail Common 09067K106 20,384,825 460,674 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Calypte Biomedical Common 131722100 4,414,010 1,433,993 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Catalytica Common 148885106 17,572,074 1,206,666 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Celgene Common 151020104 22,899,375 230,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Cor Therapeutics Common 217753102 9,888,281 150,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Corixa Common 21887F100 5,183,681 125,665 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Coulter Pharmaceutical Common 222116105 8,082,500 265,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Cubist Pharmaceuticals Common 229990981 46,607,085 1,113,005 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
CV Therapeutics Common 126667104 26,787,579 533,750 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Cytyc Common 232946103 26,284,767 544,762 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Digene Common 253752109 10,580,000 230,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Elan Warrants 284131802 2,953,500 75,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Emisphere Technologies Common 291345106 7,833,126 151,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Envirogen Common 294040100 78,124 20,833 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
EP Med Systems Common 26899B914 6,517,188 1,075,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Focal Common 343909107 2,175,816 271,977 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Gene Logic Common 368689105 9,464,063 225,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Genzyme Common 372917104 9,649,063 192,500 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Gilead Sciences Common 37555B103 22,603,264 356,659 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
IDEXX Laboratories Common 45168D104 5,828,125 250,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
ImClone Systems Common 45245W109 20,948,438 272,500 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Interpore Cross Common 46062W107 3,182,500 380,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
KeraVision Common 648990992 1,249,997 206,185 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Landec Common 514766104 3,823,821 566,492 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
LJL BioSystems Common 501873103 17,688,484 969,232 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Lynx Therapeutics Common 551812308 11,156,250 375,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Martek Biosciences Common 572901106 10,240,440 780,224 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
MedImmune Common 584699102 19,153,750 110,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Quintiles Transnational Common 748767100 2,608,857 152,900 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Sepracor Common 817315104 26,004,111 357,138 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Teva Pharmaceutical
Industries Common 881624209 3,731,250 100,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Transkaryotic Therapies Common 893735100 11,121,855 199,944 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Transkaryotic Therapies
(Restricted) Common 893735100 1,072,718 24,106 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
<PAGE>
FORM 13F
Page of Name of Reporting Manager: HAMBRECHT & QUIST CAPITAL MANAGEMENT
<TABLE>
<CAPTION>
--------------
(SEC USE ONLY)
- -----------------------------------------------------------------------------------------------------------------------------------
Item 6:
Investment Discretion Item 8:
---------------------- Voting Authority
Item 4: Item 5: (b) (Shares)
Item 2: Item 3: Fair Shares of Shared- (c) Item 7: ------------------
Item 1: Title CUSIP Market Principal (a) As Defined Shared- Managers (a) (b) (c)
Name of Issuer of Class Number Value Amount Sole in Instr. V Other See Instr. V Sole Shared None
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Triangle Pharmaceuticals Common 89589H104 4,725,000 300,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Tripath Imaging Common 896942109 570,669 63,851 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Tularik Common 899165104 10,013,504 405,405 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
Verdant Brands Common 923366108 95,000 38,000 X NA X
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
COLUMN TOTALS 450,944,476
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
